Jeffrey Mark Robbins, M.S.W.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Podiatry | 5 | 2018 | 28 | 1.290 |
Why?
|
| Diabetic Foot | 9 | 2023 | 384 | 1.070 |
Why?
|
| Ankle | 2 | 2023 | 353 | 0.720 |
Why?
|
| Societies | 1 | 2018 | 106 | 0.590 |
Why?
|
| Analgesics, Opioid | 2 | 2023 | 3835 | 0.340 |
Why?
|
| Toes | 2 | 2021 | 209 | 0.320 |
Why?
|
| Wound Healing | 2 | 2015 | 2792 | 0.240 |
Why?
|
| Lower Extremity | 2 | 2023 | 1226 | 0.220 |
Why?
|
| Wound Infection | 1 | 2006 | 244 | 0.220 |
Why?
|
| Myocardium | 5 | 2007 | 4760 | 0.220 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 3685 | 0.210 |
Why?
|
| Onychomycosis | 1 | 2003 | 50 | 0.200 |
Why?
|
| Data Display | 3 | 2006 | 174 | 0.170 |
Why?
|
| Microfilament Proteins | 1 | 2005 | 1130 | 0.170 |
Why?
|
| Clinical Competence | 1 | 2015 | 4863 | 0.160 |
Why?
|
| Myocardial Contraction | 5 | 2007 | 1515 | 0.150 |
Why?
|
| Patient Education as Topic | 1 | 2008 | 2334 | 0.150 |
Why?
|
| Antifungal Agents | 1 | 2003 | 769 | 0.140 |
Why?
|
| History, 21st Century | 3 | 2020 | 1574 | 0.140 |
Why?
|
| Physicians | 1 | 2015 | 4588 | 0.140 |
Why?
|
| History, 20th Century | 4 | 2020 | 2761 | 0.140 |
Why?
|
| Informed Consent | 1 | 2023 | 1010 | 0.130 |
Why?
|
| Myocytes, Cardiac | 6 | 2012 | 1668 | 0.130 |
Why?
|
| Carrier Proteins | 2 | 2006 | 4913 | 0.130 |
Why?
|
| Diabetes Complications | 1 | 2003 | 1316 | 0.130 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2023 | 953 | 0.120 |
Why?
|
| Operating Room Information Systems | 2 | 2005 | 15 | 0.120 |
Why?
|
| International Classification of Diseases | 1 | 2021 | 935 | 0.120 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 2 | 2007 | 195 | 0.120 |
Why?
|
| Receptor, Angiotensin, Type 2 | 2 | 2004 | 61 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 4058 | 0.110 |
Why?
|
| Patient Care Team | 4 | 2010 | 2517 | 0.110 |
Why?
|
| Heart | 2 | 2005 | 4414 | 0.100 |
Why?
|
| Hospitals, Veterans | 2 | 2006 | 395 | 0.100 |
Why?
|
| Ischemia | 1 | 2021 | 1909 | 0.100 |
Why?
|
| Diabetes Mellitus | 2 | 2021 | 5891 | 0.100 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2021 | 1175 | 0.100 |
Why?
|
| Mice, Transgenic | 8 | 2008 | 9550 | 0.090 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2012 | 197 | 0.090 |
Why?
|
| Reoperation | 1 | 2020 | 4294 | 0.080 |
Why?
|
| Systems Integration | 3 | 2006 | 427 | 0.080 |
Why?
|
| Glycogen Storage Disease Type IIb | 1 | 2007 | 18 | 0.070 |
Why?
|
| alpha-Crystallin B Chain | 1 | 2007 | 23 | 0.070 |
Why?
|
| Limb Salvage | 1 | 2010 | 488 | 0.070 |
Why?
|
| Temperature | 2 | 2024 | 2226 | 0.070 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 3230 | 0.070 |
Why?
|
| Calcineurin | 1 | 2008 | 233 | 0.070 |
Why?
|
| Telemedicine | 1 | 2024 | 3105 | 0.070 |
Why?
|
| Heart Conduction System | 1 | 2012 | 1006 | 0.070 |
Why?
|
| Neuropeptides | 1 | 2012 | 951 | 0.060 |
Why?
|
| Hospital Information Systems | 2 | 2005 | 396 | 0.060 |
Why?
|
| Heart Injuries | 1 | 2007 | 206 | 0.060 |
Why?
|
| Public Health | 1 | 2018 | 2680 | 0.060 |
Why?
|
| Energy Metabolism | 4 | 2012 | 2892 | 0.060 |
Why?
|
| Bradycardia | 1 | 2007 | 302 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2006 | 8278 | 0.060 |
Why?
|
| Curriculum | 1 | 2018 | 3782 | 0.060 |
Why?
|
| Myosins | 1 | 2006 | 408 | 0.060 |
Why?
|
| Reflex | 1 | 2007 | 376 | 0.060 |
Why?
|
| Myosin Heavy Chains | 1 | 2006 | 402 | 0.060 |
Why?
|
| Interdisciplinary Communication | 2 | 2010 | 932 | 0.060 |
Why?
|
| Multienzyme Complexes | 1 | 2007 | 663 | 0.060 |
Why?
|
| Endocrinology | 1 | 2010 | 444 | 0.060 |
Why?
|
| Sympathetic Nervous System | 1 | 2007 | 520 | 0.060 |
Why?
|
| Medical Informatics Applications | 1 | 2006 | 180 | 0.060 |
Why?
|
| Autophagy | 1 | 2012 | 1351 | 0.050 |
Why?
|
| Sarcomeres | 1 | 2006 | 379 | 0.050 |
Why?
|
| Heat-Shock Proteins | 1 | 2007 | 791 | 0.050 |
Why?
|
| Humans | 22 | 2024 | 765968 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2023 | 5946 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2006 | 1679 | 0.050 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2006 | 478 | 0.050 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2006 | 516 | 0.050 |
Why?
|
| Cardiomegaly | 1 | 2005 | 589 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2006 | 1740 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2012 | 2247 | 0.050 |
Why?
|
| Genetic Engineering | 1 | 2007 | 933 | 0.050 |
Why?
|
| Vascular Surgical Procedures | 1 | 2010 | 1485 | 0.050 |
Why?
|
| Orthopedics | 1 | 2010 | 900 | 0.050 |
Why?
|
| Myocardial Ischemia | 1 | 2012 | 2128 | 0.050 |
Why?
|
| Mice | 11 | 2012 | 81819 | 0.040 |
Why?
|
| Interviews as Topic | 3 | 2021 | 2739 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2006 | 1441 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 2012 | 2592 | 0.040 |
Why?
|
| United States | 6 | 2023 | 72903 | 0.040 |
Why?
|
| Directive Counseling | 1 | 2021 | 171 | 0.040 |
Why?
|
| Operating Rooms | 1 | 2006 | 788 | 0.040 |
Why?
|
| Heart Failure | 4 | 2008 | 11840 | 0.040 |
Why?
|
| Fibrosis | 1 | 2005 | 2070 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2007 | 2573 | 0.040 |
Why?
|
| Binding Sites | 1 | 2006 | 6001 | 0.040 |
Why?
|
| Animals | 13 | 2012 | 168764 | 0.040 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2003 | 845 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 6493 | 0.030 |
Why?
|
| Adenosine Triphosphate | 3 | 2008 | 1999 | 0.030 |
Why?
|
| Health Policy | 2 | 2010 | 2698 | 0.030 |
Why?
|
| Hydrolysis | 2 | 2007 | 642 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2012 | 14448 | 0.030 |
Why?
|
| Extremities | 1 | 2021 | 869 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 13400 | 0.030 |
Why?
|
| Stem Cells | 1 | 2007 | 3540 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 17594 | 0.030 |
Why?
|
| Cardiomyopathies | 1 | 2006 | 2067 | 0.030 |
Why?
|
| Europe | 2 | 2010 | 3423 | 0.030 |
Why?
|
| Pain, Postoperative | 1 | 2023 | 1772 | 0.030 |
Why?
|
| Echocardiography | 1 | 2005 | 5045 | 0.030 |
Why?
|
| Heart Rate | 3 | 2012 | 4204 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 3 | 2012 | 5786 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 2008 | 2548 | 0.020 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2012 | 39 | 0.020 |
Why?
|
| Animals, Genetically Modified | 2 | 2007 | 1560 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2021 | 2003 | 0.020 |
Why?
|
| Muscle Cells | 1 | 2012 | 194 | 0.020 |
Why?
|
| Oxygen Consumption | 2 | 2008 | 1870 | 0.020 |
Why?
|
| Military Personnel | 1 | 2020 | 1252 | 0.020 |
Why?
|
| Rabbits | 2 | 2007 | 4734 | 0.020 |
Why?
|
| Risk Factors | 3 | 2023 | 74840 | 0.020 |
Why?
|
| Obesity | 1 | 2012 | 13076 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2012 | 506 | 0.020 |
Why?
|
| Internet | 1 | 2021 | 3106 | 0.020 |
Why?
|
| Phenotype | 1 | 2006 | 16721 | 0.020 |
Why?
|
| Aging | 1 | 2007 | 8731 | 0.020 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2007 | 67 | 0.020 |
Why?
|
| Veratrine | 1 | 2007 | 6 | 0.020 |
Why?
|
| Dobutamine | 1 | 2007 | 114 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2008 | 3672 | 0.020 |
Why?
|
| Tetracycline | 1 | 2007 | 216 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2021 | 3925 | 0.020 |
Why?
|
| Glycogen | 1 | 2007 | 251 | 0.020 |
Why?
|
| Phosphocreatine | 1 | 2008 | 258 | 0.020 |
Why?
|
| Male | 6 | 2021 | 363698 | 0.020 |
Why?
|
| Adenosine Diphosphate | 1 | 2008 | 419 | 0.020 |
Why?
|
| North America | 1 | 2010 | 1285 | 0.020 |
Why?
|
| Electrocardiography | 2 | 2012 | 6404 | 0.020 |
Why?
|
| Atropine | 1 | 2007 | 242 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 1151 | 0.020 |
Why?
|
| Heart Ventricles | 2 | 2012 | 3832 | 0.020 |
Why?
|
| Adenosine Monophosphate | 1 | 2008 | 231 | 0.020 |
Why?
|
| Phenylephrine | 1 | 2007 | 292 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2012 | 18973 | 0.020 |
Why?
|
| Muscarinic Antagonists | 1 | 2007 | 133 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2006 | 89 | 0.020 |
Why?
|
| Veterans | 1 | 2020 | 2664 | 0.020 |
Why?
|
| Baroreflex | 1 | 2007 | 153 | 0.020 |
Why?
|
| Creatine | 1 | 2008 | 424 | 0.020 |
Why?
|
| Rats | 2 | 2012 | 23707 | 0.020 |
Why?
|
| Algorithms | 1 | 2006 | 14071 | 0.020 |
Why?
|
| Female | 6 | 2021 | 396112 | 0.020 |
Why?
|
| Information Management | 1 | 2006 | 100 | 0.020 |
Why?
|
| Propranolol | 1 | 2007 | 492 | 0.020 |
Why?
|
| Smoke | 1 | 2007 | 243 | 0.010 |
Why?
|
| Thermodynamics | 1 | 2006 | 580 | 0.010 |
Why?
|
| Ammonium Chloride | 1 | 2004 | 72 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2007 | 1263 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2007 | 499 | 0.010 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2004 | 122 | 0.010 |
Why?
|
| Database Management Systems | 1 | 2006 | 263 | 0.010 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2007 | 595 | 0.010 |
Why?
|
| Isoproterenol | 1 | 2004 | 398 | 0.010 |
Why?
|
| Vagus Nerve | 1 | 2007 | 460 | 0.010 |
Why?
|
| Dietary Fats | 1 | 2012 | 2002 | 0.010 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2004 | 132 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2006 | 471 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2004 | 153 | 0.010 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2012 | 1568 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 2004 | 655 | 0.010 |
Why?
|
| Myosin Light Chains | 1 | 2003 | 122 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 2010 | 1509 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2023 | 81514 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2012 | 2056 | 0.010 |
Why?
|
| Ventricular Function, Left | 2 | 2007 | 3928 | 0.010 |
Why?
|
| Cell Survival | 1 | 2012 | 5747 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2006 | 1689 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2007 | 1735 | 0.010 |
Why?
|
| Autonomic Nervous System | 1 | 2007 | 706 | 0.010 |
Why?
|
| Incidence | 1 | 2020 | 21480 | 0.010 |
Why?
|
| Angiotensin II | 1 | 2004 | 844 | 0.010 |
Why?
|
| Ventricular Function | 1 | 2003 | 403 | 0.010 |
Why?
|
| Cardiotonic Agents | 1 | 2004 | 538 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2007 | 1237 | 0.010 |
Why?
|
| Reperfusion Injury | 1 | 2007 | 1042 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2006 | 2669 | 0.010 |
Why?
|
| Information Storage and Retrieval | 1 | 2006 | 834 | 0.010 |
Why?
|
| Models, Animal | 1 | 2006 | 2120 | 0.010 |
Why?
|
| Glucose | 1 | 2012 | 4335 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2007 | 5020 | 0.010 |
Why?
|
| Risk Adjustment | 1 | 2003 | 596 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 2477 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 1077 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 24282 | 0.010 |
Why?
|
| Medical Order Entry Systems | 1 | 2005 | 521 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 2006 | 936 | 0.010 |
Why?
|
| Random Allocation | 1 | 2003 | 2395 | 0.010 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2004 | 934 | 0.010 |
Why?
|
| Education, Medical | 1 | 2010 | 1746 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2010 | 3956 | 0.010 |
Why?
|
| Aged | 2 | 2021 | 171117 | 0.010 |
Why?
|
| Time Factors | 2 | 2012 | 40065 | 0.010 |
Why?
|
| Middle Aged | 2 | 2021 | 223009 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 3607 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 9601 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2003 | 6220 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 11888 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 22332 | 0.010 |
Why?
|
| Disease Management | 1 | 2004 | 2535 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2012 | 12131 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2007 | 10429 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 9525 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2007 | 8532 | 0.010 |
Why?
|
| Age Factors | 1 | 2007 | 18380 | 0.010 |
Why?
|
| Gene Expression | 1 | 2003 | 7584 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2004 | 9347 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2012 | 23601 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2010 | 65188 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 2003 | 26318 | 0.000 |
Why?
|